Company: MIRA
Filing Date: 2025-07-29
Form Type: PRER14A
Source: 0001641172-25-021434
Chunk: 114

Company: MIRA PHARMACEUTICALS, INC.
Filing Date: 2025-07-29
Form: PRER14A
Chunk 114
---
 voting power present under the Company’s amended and restated bylaws, and accordingly will have the same effect as a vote “AGAINST” the outcome of this Proposal 4.

<div align='center'>THE BOARD OF DIRECTORS RECOMMENDS THAT THE STOCKHOLDERS VOTE “FOR” THE PLAN AMENDMENTS.</div>

| 63 |

<div align='center'>PROPOSAL NO. 5:

APPROVAL OF POSSIBLE ADJOURNMENT OF THE MIRA ANNUAL MEETING</div>

If MIRA fails to receive a sufficient number of votes to approve Proposal No. 1, 2, 3 or 4, MIRA may propose to postpone or adjourn the MIRA Annual Meeting, for a period of not more than 30 days, for the purpose of soliciting additional proxies to approve Proposal No. 1, 2, 3, or 4. MIRA currently does not intend to propose postponement or adjournment at the MIRA Annual Meeting if there are sufficient votes to approve Proposal No. 1, 2, 3 or 4.

The affirmative vote of a majority of the votes cast virtually or by proxy at the MIRA Annual Meeting is required to approve Proposal No. 2. Abstentions and broker non-votes will have no effect on the outcome of this Proposal. It is anticipated that Proposal No. 2 will be a discretionary proposal considered routine under the rules of the Nasdaq, which generally controls the ability of brokers to vote or not vote shares held in street name on certain matters, and thus will not result in broker non-votes.

THE MIRA BOARD RECOMMENDS THAT MIRA’S STOCKHOLDERS VOTE “FOR” PROPOSAL NO. 5 TO POSTPONE OR ADJOURN THE MIRA ANNUAL MEETING, IF NECESSARY, TO SOLICIT ADDITIONAL PROXIES IF THERE ARE NOT SUFFICIENT VOTES IN FAVOR OF PROPOSAL NO. 1. THE APPROVAL OF PROPOSAL NO. 1 IS REQUIRED TO CONSUMMATE THE MERGER.

| 64 |

<div align='center'>PRINCIPAL STOCKHOLDERS OF MIRA PHARMACEUTICALS, INC.</div>

The following table sets forth, as of the date of this proxy statement, the ownership of our securities by: (i) each of our directors, (ii) all persons who, to our knowledge, are